The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Business owners in downtown Fredericton say they are increasingly frustrated with a rise in break-ins, theft, vandalism, open ...

I have a real problem with the science behind the DRE,” said attorney Chris Langholz. “It’s junk science and it shouldn’t be ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...

Expressing concern over the decision to hike prices of eight essential drugs by 50 per cent, the Congress on Saturday urged ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...